Casey C. Kopczynski
2016
In 2016, Casey C. Kopczynski earned a total compensation of $1.2M as Chief Scientific Officer at Aerie Pharmaceuticals.
Compensation breakdown
| Bonus | $136,000 |
|---|---|
| Option Awards | $605,173 |
| Salary | $340,000 |
| Stock Awards | $150,210 |
| Total | $1,231,383 |
Kopczynski received $605.2K in option awards, accounting for 49% of the total pay in 2016.
Kopczynski also received $136K in bonus, $340K in salary and $150.2K in stock awards.
Rankings
In 2016, Casey C. Kopczynski's compensation ranked 7,257th out of 14,075 executives tracked by ExecPay. In other words, Kopczynski earned more than 48.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,257 out of 14,075 | 48th |
Division Manufacturing | 2,733 out of 5,488 | 50th |
Major group Chemicals And Allied Products | 897 out of 1,900 | 53rd |
Industry group Drugs | 697 out of 1,543 | 55th |
Industry Biological Products, Except Diagnostic Substances | 123 out of 287 | 57th |
Source: SEC filing on April 10, 2019.
Kopczynski's colleagues
We found three more compensation records of executives who worked with Casey C. Kopczynski at Aerie Pharmaceuticals in 2016.
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019